| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.33▼ | 0.33▼ | 0.33▼ | 0.36▼ | 0.39▼ |
| MA10 | 0.33▼ | 0.34▼ | 0.35▼ | 0.37▼ | 0.46▼ |
| MA20 | 0.34▼ | 0.34▼ | 0.35▼ | 0.41▼ | 0.57▼ |
| MA50 | 0.34▼ | 0.36▼ | 0.38▼ | 0.48▼ | 1.45▼ |
| MA100 | 0.34▼ | 0.38▼ | 0.40▼ | 0.63▼ | 2.11▼ |
| MA200 | 0.37▼ | 0.43▼ | 0.46▼ | 1.34▼ | 9.18▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.001▼ | -0.002▼ | -0.004▼ | 0.039▲ |
| RSI | 37.167▼ | 40.699▼ | 37.058▼ | 33.982▼ | 31.593▼ |
| STOCH | 14.141▼ | 11.187▼ | 28.385 | 37.195 | 17.920▼ |
| WILL %R | -100.000▼ | -100.000▼ | -83.368▼ | -88.849▼ | -96.695▼ |
| CCI | -134.305▼ | -104.656▼ | -90.449 | -174.265▼ | -153.033▼ |
|
Tuesday, May 12, 2026 05:18 AM
Patent Extends Jurisdiction and Protection Through 2042 ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage ...
|
|
Tuesday, May 12, 2026 05:16 AM
Patent Extends Jurisdiction and Protection Through 2042 ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharma ...
|
|
Monday, March 30, 2026 05:01 PM
Ensysce Biosciences (NASDAQ: ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the potential for abuse and overdoses that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/05/26 | 0.3309 | 0.3582 | 0.3152 | 0.3165 | 3,307,231 |
| 11/05/26 | 0.3767 | 0.3986 | 0.301 | 0.382 | 88,451,157 |
| 08/05/26 | 0.375 | 0.3803 | 0.3421 | 0.3502 | 219,038 |
| 07/05/26 | 0.399 | 0.399 | 0.37 | 0.37 | 223,754 |
| 06/05/26 | 0.405 | 0.4266 | 0.39 | 0.39 | 106,078 |
| 05/05/26 | 0.418 | 0.4354 | 0.40 | 0.40 | 158,413 |
| 04/05/26 | 0.416 | 0.4344 | 0.38 | 0.417 | 311,444 |
| 01/05/26 | 0.3808 | 0.3947 | 0.3403 | 0.389 | 369,511 |
| 30/04/26 | 0.3677 | 0.3899 | 0.361 | 0.3716 | 112,371 |
| 29/04/26 | 0.394 | 0.394 | 0.358 | 0.3613 | 247,415 |
|
|
||||
|
|
||||
|
|